{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "why is metakb not in the requirements?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "import json\n",
    "import pronto"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>FDA Brand Label</th>\n",
       "      <th>INDICATION 2</th>\n",
       "      <th>PEDIATRIC APPROVAL DATE 3*</th>\n",
       "      <th>Variation</th>\n",
       "      <th>GENE_ID</th>\n",
       "      <th>GENETIC_LABELS</th>\n",
       "      <th>DISEASE_LABELS</th>\n",
       "      <th>DISEASE_ID</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Asparaginase [Elspar]</td>\n",
       "      <td>As a component of a multi-agent chemotherapeut...</td>\n",
       "      <td>01-10-1978</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>acute lymphoblastic leukemia (ALL)</td>\n",
       "      <td>MONDO:0004967</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Asparaginase Erwinia chrysanthemi (recombinant...</td>\n",
       "      <td>As a component of a multi-agent chemotherapeut...</td>\n",
       "      <td>06-30-2021</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>hypersensitivity to E. coli-derived asparagina...</td>\n",
       "      <td>MONDO:0005271</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Asparaginase Erwinia chrysanthemi (recombinant...</td>\n",
       "      <td>As a component of a multi-agent chemotherapeut...</td>\n",
       "      <td>06-30-2021</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>lymphoblastic lymphoma (LBL)</td>\n",
       "      <td>MONDO:0000873</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Asparaginase Erwinia chrysanthemi (recombinant...</td>\n",
       "      <td>As a component of a multi-agent chemotherapeut...</td>\n",
       "      <td>06-30-2021</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>acute lymphoblastic leukemia (ALL)</td>\n",
       "      <td>MONDO:0004967</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Asparaginase Erwinia Chrysanthemi [Erwinaze] [...</td>\n",
       "      <td>A component of a multi-agent chemotherapeutic ...</td>\n",
       "      <td>11-18-2011</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>acute lymphoblastic leukemia (ALL)</td>\n",
       "      <td>MONDO:0004967</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>Trametinib [Mekinist]</td>\n",
       "      <td>In combination with dabrafenib, for the treatm...</td>\n",
       "      <td>8-31-2023 *</td>\n",
       "      <td>V600E mutation</td>\n",
       "      <td>HGNC:1097</td>\n",
       "      <td>BRAF</td>\n",
       "      <td>metastatic neoplasm</td>\n",
       "      <td>MONDO:0024883</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>Trametinib [Mekinist]</td>\n",
       "      <td>In combination with dabrafenib, for the treatm...</td>\n",
       "      <td>03-16-2023</td>\n",
       "      <td>V600E mutation</td>\n",
       "      <td>HGNC:1097</td>\n",
       "      <td>BRAF</td>\n",
       "      <td>Low Grade Glioma</td>\n",
       "      <td>MONDO:0021637</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>110 rows Ã— 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                       FDA Brand Label  \\\n",
       "0                                Asparaginase [Elspar]   \n",
       "1    Asparaginase Erwinia chrysanthemi (recombinant...   \n",
       "2    Asparaginase Erwinia chrysanthemi (recombinant...   \n",
       "3    Asparaginase Erwinia chrysanthemi (recombinant...   \n",
       "4    Asparaginase Erwinia Chrysanthemi [Erwinaze] [...   \n",
       "..                                                 ...   \n",
       "105                              Trametinib [Mekinist]   \n",
       "106                              Trametinib [Mekinist]   \n",
       "107                                                NaN   \n",
       "108                                                NaN   \n",
       "109                                                NaN   \n",
       "\n",
       "                                          INDICATION 2  \\\n",
       "0    As a component of a multi-agent chemotherapeut...   \n",
       "1    As a component of a multi-agent chemotherapeut...   \n",
       "2    As a component of a multi-agent chemotherapeut...   \n",
       "3    As a component of a multi-agent chemotherapeut...   \n",
       "4    A component of a multi-agent chemotherapeutic ...   \n",
       "..                                                 ...   \n",
       "105  In combination with dabrafenib, for the treatm...   \n",
       "106  In combination with dabrafenib, for the treatm...   \n",
       "107                                                NaN   \n",
       "108                                                NaN   \n",
       "109                                                NaN   \n",
       "\n",
       "    PEDIATRIC APPROVAL DATE 3*       Variation    GENE_ID GENETIC_LABELS  \\\n",
       "0                   01-10-1978              --        NaN             --   \n",
       "1                   06-30-2021              --        NaN             --   \n",
       "2                   06-30-2021              --        NaN             --   \n",
       "3                   06-30-2021              --        NaN             --   \n",
       "4                   11-18-2011              --        NaN             --   \n",
       "..                         ...             ...        ...            ...   \n",
       "105                8-31-2023 *  V600E mutation  HGNC:1097           BRAF   \n",
       "106                 03-16-2023  V600E mutation  HGNC:1097           BRAF   \n",
       "107                        NaN             NaN        NaN            NaN   \n",
       "108                        NaN             NaN        NaN            NaN   \n",
       "109                        NaN             NaN        NaN            NaN   \n",
       "\n",
       "                                        DISEASE_LABELS     DISEASE_ID  \n",
       "0                   acute lymphoblastic leukemia (ALL)  MONDO:0004967  \n",
       "1    hypersensitivity to E. coli-derived asparagina...  MONDO:0005271  \n",
       "2                        lymphoblastic lymphoma (LBL)   MONDO:0000873  \n",
       "3                   acute lymphoblastic leukemia (ALL)  MONDO:0004967  \n",
       "4                   acute lymphoblastic leukemia (ALL)  MONDO:0004967  \n",
       "..                                                 ...            ...  \n",
       "105                                metastatic neoplasm  MONDO:0024883  \n",
       "106                                   Low Grade Glioma  MONDO:0021637  \n",
       "107                                                NaN            NaN  \n",
       "108                                                NaN            NaN  \n",
       "109                                                NaN            NaN  \n",
       "\n",
       "[110 rows x 8 columns]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "annotated_poda_df = pd.read_csv(\n",
    "    \"../../../../Pediatric dataset annotations.csv\", sep=\",\"\n",
    ")\n",
    "annotated_poda_df = annotated_poda_df.loc[:, ~annotated_poda_df.columns.str.startswith(\"Unnamed\")]\n",
    "annotated_poda_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "key_map = {\n",
    "    \"INDICATION 2\": \"description\",\n",
    "    \"GENETIC_LABELS\": \"geneContextQualifier\",\n",
    "    \"FDA Brand Label\": \"objectTherapeutic\"\n",
    "}\n",
    "multi_value_column = \"GENETIC_LABELS\"\n",
    "\n",
    "prop_type = \"VariantTherapeuticResponseProposition\"\n",
    "predicate = \"sensitivity\"\n",
    "\n",
    "output_dir = \"../../../../json_outputs\"\n",
    "\n",
    "for idx, row in annotated_poda_df.iterrows():\n",
    "    values = [v.strip() for v in str(row[multi_value_column]).split(\",\")]\n",
    "\n",
    "    for i, val in enumerate(values):\n",
    "        json_obj = {\"type\": prop_type, \"predicate\": predicate}\n",
    "\n",
    "        for col in key_map:\n",
    "            key = key_map[col]\n",
    "            value = val if col == multi_value_column else row[col]\n",
    "            json_obj[key] = value\n",
    "\n",
    "        filename = f\"row_{idx}_{i}.json\"\n",
    "        filepath = os.path.join(output_dir, filename)\n",
    "\n",
    "        with open(filepath, \"w\") as f:\n",
    "            json.dump(json_obj, f, indent=4)\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "earlier the link was working which is preferable but now it is the local copy of mondo.obo"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/vt/znzp_c6s02q6kjcmqfk0cb500000gq/T/ipykernel_18486/3556618749.py:2: UnicodeWarning: unsound encoding, assuming utf-8 (99% confidence)\n",
      "  ontology = pronto.Ontology(\"mondo.obo\")\n"
     ]
    }
   ],
   "source": [
    "# Load the OBO file\n",
    "ontology = pronto.Ontology(\"mondo.obo\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "cleaned_annotated_poda_df = annotated_poda_df.copy()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "cleaned_annotated_poda_df['DISEASE_LABELS'] = cleaned_annotated_poda_df['DISEASE_LABELS'].str.replace(r'\\s*\\([^)]*\\)\\s*', '', regex=True)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [],
   "source": [
    "search_terms = cleaned_annotated_poda_df[\"DISEASE_LABELS\"].dropna()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [],
   "source": [
    "results = []\n",
    "\n",
    "for idx, search_string in search_terms.items():\n",
    "    if search_string == \"--\":\n",
    "        results.append({\n",
    "            \"index\": idx,\n",
    "            \"method_ID\": None,\n",
    "            \"method_name\": None,\n",
    "            \"method_match_type\": \"skipped\"\n",
    "        })\n",
    "        continue\n",
    "\n",
    "    exact_match = None\n",
    "    match_candidates = []\n",
    "\n",
    "    # 1. Exact match on term name\n",
    "    for term in ontology.terms():\n",
    "        if (\n",
    "            term.id and term.id.startswith(\"MONDO\") and\n",
    "            term.name and term.name.lower() == search_string.lower()\n",
    "        ):\n",
    "            exact_match = term\n",
    "            break\n",
    "\n",
    "    if exact_match:\n",
    "        results.append({\n",
    "            \"index\": idx,\n",
    "            \"method_ID\": exact_match.id,\n",
    "            \"method_name\": exact_match.name,\n",
    "            \"method_match_type\": \"exact match\"\n",
    "        })\n",
    "        continue  # skip synonym matching\n",
    "\n",
    "    # 2. Synonym match\n",
    "    for term in ontology.terms():\n",
    "        if term.id and term.id.startswith(\"MONDO\") and term.synonyms:\n",
    "            for syn in term.synonyms:\n",
    "                if syn.description.lower() == search_string.lower():\n",
    "                    scope = syn.scope.upper() if syn.scope else ''\n",
    "                    rank = {'EXACT': 2, 'RELATED': 1}.get(scope, 0)\n",
    "                    match_candidates.append((rank, term, scope))\n",
    "                    break  # only first matching synonym per term\n",
    "\n",
    "    if match_candidates:\n",
    "        match_candidates.sort(reverse=True, key=lambda x: x[0])\n",
    "        top_rank = match_candidates[0][0]\n",
    "        top_matches = [item for item in match_candidates if item[0] == top_rank]\n",
    "\n",
    "        # We'll take the first top match for consistency\n",
    "        _, top_term, scope = top_matches[0]\n",
    "        match_type = (\n",
    "            \"exact synonym match\" if top_rank == 2\n",
    "            else \"other synonym match\"\n",
    "        )\n",
    "\n",
    "        results.append({\n",
    "            \"index\": idx,\n",
    "            \"method_ID\": top_term.id,\n",
    "            \"method_name\": top_term.name,\n",
    "            \"method_match_type\": match_type\n",
    "        })\n",
    "    else:\n",
    "        results.append({\n",
    "            \"index\": idx,\n",
    "            \"method_ID\": None,\n",
    "            \"method_name\": None,\n",
    "            \"method_match_type\": \"no match\"\n",
    "        })\n",
    "\n",
    "# Convert results list to DataFrame\n",
    "match_df = pd.DataFrame(results).set_index(\"index\")\n",
    "\n",
    "# Merge match results back into a copy of the original DataFrame\n",
    "annotated_with_matches_df = cleaned_annotated_poda_df.copy()\n",
    "annotated_with_matches_df = annotated_with_matches_df.join(match_df)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>FDA Brand Label</th>\n",
       "      <th>INDICATION 2</th>\n",
       "      <th>PEDIATRIC APPROVAL DATE 3*</th>\n",
       "      <th>Variation</th>\n",
       "      <th>GENE_ID</th>\n",
       "      <th>GENETIC_LABELS</th>\n",
       "      <th>DISEASE_LABELS</th>\n",
       "      <th>DISEASE_ID</th>\n",
       "      <th>method_ID</th>\n",
       "      <th>method_name</th>\n",
       "      <th>method_match_type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Asparaginase [Elspar]</td>\n",
       "      <td>As a component of a multi-agent chemotherapeut...</td>\n",
       "      <td>01-10-1978</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>acute lymphoblastic leukemia</td>\n",
       "      <td>MONDO:0004967</td>\n",
       "      <td>MONDO:0004967</td>\n",
       "      <td>acute lymphoblastic leukemia</td>\n",
       "      <td>exact match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Asparaginase Erwinia chrysanthemi (recombinant...</td>\n",
       "      <td>As a component of a multi-agent chemotherapeut...</td>\n",
       "      <td>06-30-2021</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>hypersensitivity to E. coli-derived asparagina...</td>\n",
       "      <td>MONDO:0005271</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Asparaginase Erwinia chrysanthemi (recombinant...</td>\n",
       "      <td>As a component of a multi-agent chemotherapeut...</td>\n",
       "      <td>06-30-2021</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>lymphoblastic lymphoma</td>\n",
       "      <td>MONDO:0000873</td>\n",
       "      <td>MONDO:0000873</td>\n",
       "      <td>lymphoblastic lymphoma</td>\n",
       "      <td>exact match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Asparaginase Erwinia chrysanthemi (recombinant...</td>\n",
       "      <td>As a component of a multi-agent chemotherapeut...</td>\n",
       "      <td>06-30-2021</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>acute lymphoblastic leukemia</td>\n",
       "      <td>MONDO:0004967</td>\n",
       "      <td>MONDO:0004967</td>\n",
       "      <td>acute lymphoblastic leukemia</td>\n",
       "      <td>exact match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Asparaginase Erwinia Chrysanthemi [Erwinaze] [...</td>\n",
       "      <td>A component of a multi-agent chemotherapeutic ...</td>\n",
       "      <td>11-18-2011</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>acute lymphoblastic leukemia</td>\n",
       "      <td>MONDO:0004967</td>\n",
       "      <td>MONDO:0004967</td>\n",
       "      <td>acute lymphoblastic leukemia</td>\n",
       "      <td>exact match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>Trametinib [Mekinist]</td>\n",
       "      <td>In combination with dabrafenib, for the treatm...</td>\n",
       "      <td>8-31-2023 *</td>\n",
       "      <td>V600E mutation</td>\n",
       "      <td>HGNC:1097</td>\n",
       "      <td>BRAF</td>\n",
       "      <td>metastatic neoplasm</td>\n",
       "      <td>MONDO:0024883</td>\n",
       "      <td>MONDO:0024883</td>\n",
       "      <td>metastatic neoplasm</td>\n",
       "      <td>exact match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>Trametinib [Mekinist]</td>\n",
       "      <td>In combination with dabrafenib, for the treatm...</td>\n",
       "      <td>03-16-2023</td>\n",
       "      <td>V600E mutation</td>\n",
       "      <td>HGNC:1097</td>\n",
       "      <td>BRAF</td>\n",
       "      <td>Low Grade Glioma</td>\n",
       "      <td>MONDO:0021637</td>\n",
       "      <td>MONDO:0021637</td>\n",
       "      <td>low grade glioma</td>\n",
       "      <td>exact match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>110 rows Ã— 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                       FDA Brand Label  \\\n",
       "0                                Asparaginase [Elspar]   \n",
       "1    Asparaginase Erwinia chrysanthemi (recombinant...   \n",
       "2    Asparaginase Erwinia chrysanthemi (recombinant...   \n",
       "3    Asparaginase Erwinia chrysanthemi (recombinant...   \n",
       "4    Asparaginase Erwinia Chrysanthemi [Erwinaze] [...   \n",
       "..                                                 ...   \n",
       "105                              Trametinib [Mekinist]   \n",
       "106                              Trametinib [Mekinist]   \n",
       "107                                                NaN   \n",
       "108                                                NaN   \n",
       "109                                                NaN   \n",
       "\n",
       "                                          INDICATION 2  \\\n",
       "0    As a component of a multi-agent chemotherapeut...   \n",
       "1    As a component of a multi-agent chemotherapeut...   \n",
       "2    As a component of a multi-agent chemotherapeut...   \n",
       "3    As a component of a multi-agent chemotherapeut...   \n",
       "4    A component of a multi-agent chemotherapeutic ...   \n",
       "..                                                 ...   \n",
       "105  In combination with dabrafenib, for the treatm...   \n",
       "106  In combination with dabrafenib, for the treatm...   \n",
       "107                                                NaN   \n",
       "108                                                NaN   \n",
       "109                                                NaN   \n",
       "\n",
       "    PEDIATRIC APPROVAL DATE 3*       Variation    GENE_ID GENETIC_LABELS  \\\n",
       "0                   01-10-1978              --        NaN             --   \n",
       "1                   06-30-2021              --        NaN             --   \n",
       "2                   06-30-2021              --        NaN             --   \n",
       "3                   06-30-2021              --        NaN             --   \n",
       "4                   11-18-2011              --        NaN             --   \n",
       "..                         ...             ...        ...            ...   \n",
       "105                8-31-2023 *  V600E mutation  HGNC:1097           BRAF   \n",
       "106                 03-16-2023  V600E mutation  HGNC:1097           BRAF   \n",
       "107                        NaN             NaN        NaN            NaN   \n",
       "108                        NaN             NaN        NaN            NaN   \n",
       "109                        NaN             NaN        NaN            NaN   \n",
       "\n",
       "                                        DISEASE_LABELS     DISEASE_ID  \\\n",
       "0                         acute lymphoblastic leukemia  MONDO:0004967   \n",
       "1    hypersensitivity to E. coli-derived asparagina...  MONDO:0005271   \n",
       "2                               lymphoblastic lymphoma  MONDO:0000873   \n",
       "3                         acute lymphoblastic leukemia  MONDO:0004967   \n",
       "4                         acute lymphoblastic leukemia  MONDO:0004967   \n",
       "..                                                 ...            ...   \n",
       "105                                metastatic neoplasm  MONDO:0024883   \n",
       "106                                   Low Grade Glioma  MONDO:0021637   \n",
       "107                                                NaN            NaN   \n",
       "108                                                NaN            NaN   \n",
       "109                                                NaN            NaN   \n",
       "\n",
       "         method_ID                   method_name method_match_type  \n",
       "0    MONDO:0004967  acute lymphoblastic leukemia       exact match  \n",
       "1             None                          None          no match  \n",
       "2    MONDO:0000873        lymphoblastic lymphoma       exact match  \n",
       "3    MONDO:0004967  acute lymphoblastic leukemia       exact match  \n",
       "4    MONDO:0004967  acute lymphoblastic leukemia       exact match  \n",
       "..             ...                           ...               ...  \n",
       "105  MONDO:0024883           metastatic neoplasm       exact match  \n",
       "106  MONDO:0021637              low grade glioma       exact match  \n",
       "107            NaN                           NaN               NaN  \n",
       "108            NaN                           NaN               NaN  \n",
       "109            NaN                           NaN               NaN  \n",
       "\n",
       "[110 rows x 11 columns]"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "annotated_with_matches_df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "in all the cases below, the method annotation is more accurate."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>FDA Brand Label</th>\n",
       "      <th>INDICATION 2</th>\n",
       "      <th>PEDIATRIC APPROVAL DATE 3*</th>\n",
       "      <th>Variation</th>\n",
       "      <th>GENE_ID</th>\n",
       "      <th>GENETIC_LABELS</th>\n",
       "      <th>DISEASE_LABELS</th>\n",
       "      <th>DISEASE_ID</th>\n",
       "      <th>method_ID</th>\n",
       "      <th>method_name</th>\n",
       "      <th>method_match_type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Iobenguane I-131 [Azedra]</td>\n",
       "      <td>Treatment of adult and pediatric patients 12 y...</td>\n",
       "      <td>07-30-2018</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>pheochromocytoma-paraganglioma</td>\n",
       "      <td>MONDO:0017366</td>\n",
       "      <td>MONDO:0035540</td>\n",
       "      <td>pheochromocytoma-paraganglioma</td>\n",
       "      <td>exact match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>Arsenic trioxide [Trisenox]</td>\n",
       "      <td>Induction of remission and consolidation in pa...</td>\n",
       "      <td>09-25-2000</td>\n",
       "      <td>translocation</td>\n",
       "      <td>HGNC:9113 | HGNC:9864</td>\n",
       "      <td>PML | RARA</td>\n",
       "      <td>Acute Promyelocytic Leukemia with PML-RARA</td>\n",
       "      <td>MONDO:0100375</td>\n",
       "      <td>MONDO:0012883</td>\n",
       "      <td>acute promyelocytic leukemia</td>\n",
       "      <td>exact synonym match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>Revumenib [Revuforj]</td>\n",
       "      <td>Treatment of relapsed or refractory acute leuk...</td>\n",
       "      <td>11-15-2024</td>\n",
       "      <td>Translocation</td>\n",
       "      <td>HGNC:7132</td>\n",
       "      <td>KMT2A</td>\n",
       "      <td>Acute Undifferentiated Leukemia</td>\n",
       "      <td>MONDO:0010643</td>\n",
       "      <td>MONDO:0020321</td>\n",
       "      <td>acute undifferentiated leukemia</td>\n",
       "      <td>exact match</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 FDA Brand Label  \\\n",
       "29     Iobenguane I-131 [Azedra]   \n",
       "100  Arsenic trioxide [Trisenox]   \n",
       "101         Revumenib [Revuforj]   \n",
       "\n",
       "                                          INDICATION 2  \\\n",
       "29   Treatment of adult and pediatric patients 12 y...   \n",
       "100  Induction of remission and consolidation in pa...   \n",
       "101  Treatment of relapsed or refractory acute leuk...   \n",
       "\n",
       "    PEDIATRIC APPROVAL DATE 3*      Variation                GENE_ID  \\\n",
       "29                  07-30-2018             --                    NaN   \n",
       "100                 09-25-2000  translocation  HGNC:9113 | HGNC:9864   \n",
       "101                 11-15-2024  Translocation              HGNC:7132   \n",
       "\n",
       "    GENETIC_LABELS                              DISEASE_LABELS     DISEASE_ID  \\\n",
       "29              --              pheochromocytoma-paraganglioma  MONDO:0017366   \n",
       "100     PML | RARA  Acute Promyelocytic Leukemia with PML-RARA  MONDO:0100375   \n",
       "101          KMT2A             Acute Undifferentiated Leukemia  MONDO:0010643   \n",
       "\n",
       "         method_ID                      method_name    method_match_type  \n",
       "29   MONDO:0035540   pheochromocytoma-paraganglioma          exact match  \n",
       "100  MONDO:0012883     acute promyelocytic leukemia  exact synonym match  \n",
       "101  MONDO:0020321  acute undifferentiated leukemia          exact match  "
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mismatched_rows = annotated_with_matches_df[\n",
    "    (annotated_with_matches_df[\"DISEASE_ID\"] != annotated_with_matches_df[\"method_ID\"]) &\n",
    "    (annotated_with_matches_df[\"method_ID\"].notna())\n",
    "]\n",
    "mismatched_rows\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>FDA Brand Label</th>\n",
       "      <th>INDICATION 2</th>\n",
       "      <th>PEDIATRIC APPROVAL DATE 3*</th>\n",
       "      <th>Variation</th>\n",
       "      <th>GENE_ID</th>\n",
       "      <th>GENETIC_LABELS</th>\n",
       "      <th>DISEASE_LABELS</th>\n",
       "      <th>DISEASE_ID</th>\n",
       "      <th>method_ID</th>\n",
       "      <th>method_name</th>\n",
       "      <th>method_match_type</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Asparaginase Erwinia chrysanthemi (recombinant...</td>\n",
       "      <td>As a component of a multi-agent chemotherapeut...</td>\n",
       "      <td>06-30-2021</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>hypersensitivity to E. coli-derived asparagina...</td>\n",
       "      <td>MONDO:0005271</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Asparaginase Erwinia Chrysanthemi [Erwinaze] [...</td>\n",
       "      <td>A component of a multi-agent chemotherapeutic ...</td>\n",
       "      <td>11-18-2011</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>hypersensitivity to E. coli-derived asparagina...</td>\n",
       "      <td>MONDO:0005271</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Cyclophosphamide [Cytoxan]</td>\n",
       "      <td>MULTIPLE</td>\n",
       "      <td>11-16-1959</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>skipped</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Daunorubicin and cytarabine liposome [Vyxeos]</td>\n",
       "      <td>Treatment of newly-diagnosed therapy-related a...</td>\n",
       "      <td>03-30-2021</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>therapy related acute myeloid leukemia/AML wit...</td>\n",
       "      <td>MONDO:0019457</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Doxorubicin Hydrochloride</td>\n",
       "      <td>MULTIPLE</td>\n",
       "      <td>08-07-1974</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>skipped</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>Larotrectinib [Vitrakvi]</td>\n",
       "      <td>Treatment of adult and pediatric patients with...</td>\n",
       "      <td>11-26-2018</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>solid tumors that have a neurotrophic receptor...</td>\n",
       "      <td>MONDO:0700215</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Lutetium Lu 177 dotatate [Lutathera]</td>\n",
       "      <td>Treatment of adult and pediatric patients 12 y...</td>\n",
       "      <td>04-23-2024</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>gastroenteropancreatic neuroendocrine tumors</td>\n",
       "      <td>MONDO:0024503</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>Methotrexate</td>\n",
       "      <td>Treatment of adults and pediatric patients wit...</td>\n",
       "      <td>12-07-1953</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>Non-hodgkin Lymphoma</td>\n",
       "      <td>MONDO:0018908</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Methotrexate</td>\n",
       "      <td>Treatment of adults and pediatric patients wit...</td>\n",
       "      <td>12-07-1953</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>Osteosarcoma</td>\n",
       "      <td>MONDO:0009807</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Nelarabine [Arranon]</td>\n",
       "      <td>Treatment of T-cell acute lymphoblastic leukem...</td>\n",
       "      <td>10-28-2005</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>T-cell lymphoblastic lymphoma</td>\n",
       "      <td>MONDO:0044917</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>Pegaspargase [Oncaspar]</td>\n",
       "      <td>As a component of a multi-agent chemotherapeut...</td>\n",
       "      <td>02-01-1994</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>hypersensitivity to native forms of L-asparagi...</td>\n",
       "      <td>MONDO:0005271</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Pembrolizumab [Keytruda]</td>\n",
       "      <td>Treatment of adult and pediatric patients with...</td>\n",
       "      <td>06-16-2020</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>mutational burden-high[â‰¥10 mutations/megabase]...</td>\n",
       "      <td>MONDO:0005070</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Pembrolizumab [Keytruda]</td>\n",
       "      <td>Treatment of adult and pediatric patients with...</td>\n",
       "      <td>05-23-2017</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>mismatch repair deficientsolid tumors | Neoplasm</td>\n",
       "      <td>MONDO:0005070</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>Pembrolizumab [Keytruda]</td>\n",
       "      <td>Treatment of adult and pediatric patients with...</td>\n",
       "      <td>05-23-2017</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>microsatellite instability-highsolid tumors | ...</td>\n",
       "      <td>MONDO:0005070</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>Selumetinib [Koselugo]</td>\n",
       "      <td>Treatment of pediatric patients 2 years of age...</td>\n",
       "      <td>04-10-2020</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>Neurofibromatosis Type 1</td>\n",
       "      <td>MONDO:0018975</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>Tagraxofusp-erzs [Elzonris]</td>\n",
       "      <td>Treatment of blastic plasmacytoid dendritic ce...</td>\n",
       "      <td>12-21-2018</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>Blastic Plasmacytoid Dendritic Cell Neoplasm |...</td>\n",
       "      <td>MONDO:0005070</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>Thioguanine [Tabloid]</td>\n",
       "      <td>Remission induction and remission consolidatio...</td>\n",
       "      <td>--</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>Acute nonlymphocytic leukemia | acute myeloid ...</td>\n",
       "      <td>MONDO:0018874</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>Tisagenlecleucel [Kymriah]</td>\n",
       "      <td>Treatment of patients up to 25 years of age wi...</td>\n",
       "      <td>08-30-2017</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>B-cell precursor acute lymphoblastic leukemia</td>\n",
       "      <td>MONDO:0020511</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>Vinblastine sulfate</td>\n",
       "      <td>Palliative treatment of malignancies including...</td>\n",
       "      <td>11-25-1965</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>testicular germ cell carcinoma</td>\n",
       "      <td>MONDO:0010108</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>Vinblastine sulfate</td>\n",
       "      <td>Palliative treatment of malignancies including...</td>\n",
       "      <td>11-25-1965</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>histiocytosis X</td>\n",
       "      <td>MONDO:0018310</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>Vinblastine sulfate</td>\n",
       "      <td>Palliative treatment of malignancies including...</td>\n",
       "      <td>11-25-1965</td>\n",
       "      <td>--</td>\n",
       "      <td>NaN</td>\n",
       "      <td>--</td>\n",
       "      <td>Hodgkinâ€™s disease</td>\n",
       "      <td>MONDO:0004952</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>Bosutinib [Bosulif]</td>\n",
       "      <td>Treatment of adult and pediatric patients 1 ye...</td>\n",
       "      <td>09-26-2023</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:1014 | HGNC:76</td>\n",
       "      <td>BCR | ABL1</td>\n",
       "      <td>Philadelphia chromosome positive chronic myelo...</td>\n",
       "      <td>MONDO:0011996</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>Vorasidenib [Voranigo]</td>\n",
       "      <td>Treatment of adult and pediatric patients 12 y...</td>\n",
       "      <td>08-06-2024</td>\n",
       "      <td>Mutation</td>\n",
       "      <td>HGNC:5382 | HGNC:5383</td>\n",
       "      <td>IDH1 | IDH2</td>\n",
       "      <td>Grade 2 astrocytoma</td>\n",
       "      <td>MONDO:0021638</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Blinatumomab [Blincyto]</td>\n",
       "      <td>Treatment of CD19-positive Philadelphia chromo...</td>\n",
       "      <td>06-14-2024</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:1633</td>\n",
       "      <td>CD19</td>\n",
       "      <td>B-cell precursor acute lymphoblastic leukemia</td>\n",
       "      <td>MONDO:0020511</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td>Crizotinib [Xalkori]</td>\n",
       "      <td>Treatment of adult and pediatric patients 1 ye...</td>\n",
       "      <td>07-14-2022</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:427</td>\n",
       "      <td>ALK</td>\n",
       "      <td>Inflammatory Myofibroblastic Tumor</td>\n",
       "      <td>MONDO:0015798</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>Dasatinib [Sprycel]</td>\n",
       "      <td>Treatment of pediatric patients 1 year of age ...</td>\n",
       "      <td>12-21-2018</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:1014 | HGNC:76</td>\n",
       "      <td>BCR | ABL1</td>\n",
       "      <td>Acute Lymphoblastic Leukemia</td>\n",
       "      <td>MONDO:0004967</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>Dasatinib [Sprycel]</td>\n",
       "      <td>Treatment of pediatric patients 1 year of age ...</td>\n",
       "      <td>11-09-2017</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:1014 | HGNC:76</td>\n",
       "      <td>BCR | ABL1</td>\n",
       "      <td>Philadelphia chromosome positive chronic myelo...</td>\n",
       "      <td>MONDO:0011996</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>Imatinib Mesylate [Gleevec] &amp;</td>\n",
       "      <td>Pediatric patients with newly diagnosed Philad...</td>\n",
       "      <td>01-25-2013</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:1014 | HGNC:76</td>\n",
       "      <td>BCR | ABL1</td>\n",
       "      <td>Acute Lymphoblastic Leukemia</td>\n",
       "      <td>MONDO:0004967</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>Imatinib Mesylate [Gleevec] &amp;</td>\n",
       "      <td>Newly diagnosed adult and pediatric patients w...</td>\n",
       "      <td>09-27-2006</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:1014 | HGNC:76</td>\n",
       "      <td>BCR | ABL1</td>\n",
       "      <td>Philadelphia chromosome positive chronic myelo...</td>\n",
       "      <td>MONDO:0011996</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>Inotuzumab ozogamicin [Besponsa]</td>\n",
       "      <td>Treatment of relapsed or refractory CD22-posit...</td>\n",
       "      <td>03-06-2024</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:1643</td>\n",
       "      <td>CD22</td>\n",
       "      <td>B-cell precursor acute lymphoblastic leukemia</td>\n",
       "      <td>MONDO:0020511</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>Nilotinib [Tasigna]</td>\n",
       "      <td>Treatment of adult and pediatric patients grea...</td>\n",
       "      <td>03-22-2018</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:1014 | HGNC:76</td>\n",
       "      <td>BCR | ABL1</td>\n",
       "      <td>Philadelphia chromosome positive chronic myelo...</td>\n",
       "      <td>MONDO:0011996</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>Nilotinib [Tasigna]</td>\n",
       "      <td>Treatment of pediatric patients greater than o...</td>\n",
       "      <td>03-22-2018</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:1014 | HGNC:76</td>\n",
       "      <td>BCR | ABL1</td>\n",
       "      <td>accelerated phase Philadelphia chromosome posi...</td>\n",
       "      <td>MONDO:0021367</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>Nilotinib [Tasigna]</td>\n",
       "      <td>Treatment of pediatric patients greater than o...</td>\n",
       "      <td>03-22-2018</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:1014 | HGNC:76</td>\n",
       "      <td>BCR | ABL1</td>\n",
       "      <td>Philadelphia chromosome positive chronic myelo...</td>\n",
       "      <td>MONDO:0011996</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>Rituximab [Rituxan]</td>\n",
       "      <td>Treatment of pediatric patients aged 6 months ...</td>\n",
       "      <td>12-02-2021</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:7315</td>\n",
       "      <td>MS4A1</td>\n",
       "      <td>B-cell acute leukemia</td>\n",
       "      <td>MONDO:0004947</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>Rituximab [Rituxan]</td>\n",
       "      <td>Treatment of pediatric patients aged 6 months ...</td>\n",
       "      <td>12-02-2021</td>\n",
       "      <td>positive</td>\n",
       "      <td>HGNC:7315</td>\n",
       "      <td>MS4A1</td>\n",
       "      <td>Burkitt-like lymphoma</td>\n",
       "      <td>MONDO:0003658</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>no match</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                       FDA Brand Label  \\\n",
       "1    Asparaginase Erwinia chrysanthemi (recombinant...   \n",
       "5    Asparaginase Erwinia Chrysanthemi [Erwinaze] [...   \n",
       "14                          Cyclophosphamide [Cytoxan]   \n",
       "20       Daunorubicin and cytarabine liposome [Vyxeos]   \n",
       "24                           Doxorubicin Hydrochloride   \n",
       "32                            Larotrectinib [Vitrakvi]   \n",
       "35                Lutetium Lu 177 dotatate [Lutathera]   \n",
       "39                                        Methotrexate   \n",
       "40                                        Methotrexate   \n",
       "42                                Nelarabine [Arranon]   \n",
       "50                             Pegaspargase [Oncaspar]   \n",
       "53                            Pembrolizumab [Keytruda]   \n",
       "56                            Pembrolizumab [Keytruda]   \n",
       "57                            Pembrolizumab [Keytruda]   \n",
       "59                              Selumetinib [Koselugo]   \n",
       "60                         Tagraxofusp-erzs [Elzonris]   \n",
       "62                               Thioguanine [Tabloid]   \n",
       "63                          Tisagenlecleucel [Kymriah]   \n",
       "64                                 Vinblastine sulfate   \n",
       "65                                 Vinblastine sulfate   \n",
       "66                                 Vinblastine sulfate   \n",
       "71                                 Bosutinib [Bosulif]   \n",
       "80                              Vorasidenib [Voranigo]   \n",
       "81                             Blinatumomab [Blincyto]   \n",
       "84                                Crizotinib [Xalkori]   \n",
       "86                                 Dasatinib [Sprycel]   \n",
       "87                                 Dasatinib [Sprycel]   \n",
       "90                       Imatinib Mesylate [Gleevec] &   \n",
       "91                       Imatinib Mesylate [Gleevec] &   \n",
       "92                    Inotuzumab ozogamicin [Besponsa]   \n",
       "93                                 Nilotinib [Tasigna]   \n",
       "94                                 Nilotinib [Tasigna]   \n",
       "95                                 Nilotinib [Tasigna]   \n",
       "96                                 Rituximab [Rituxan]   \n",
       "97                                 Rituximab [Rituxan]   \n",
       "107                                                NaN   \n",
       "108                                                NaN   \n",
       "109                                                NaN   \n",
       "\n",
       "                                          INDICATION 2  \\\n",
       "1    As a component of a multi-agent chemotherapeut...   \n",
       "5    A component of a multi-agent chemotherapeutic ...   \n",
       "14                                            MULTIPLE   \n",
       "20   Treatment of newly-diagnosed therapy-related a...   \n",
       "24                                            MULTIPLE   \n",
       "32   Treatment of adult and pediatric patients with...   \n",
       "35   Treatment of adult and pediatric patients 12 y...   \n",
       "39   Treatment of adults and pediatric patients wit...   \n",
       "40   Treatment of adults and pediatric patients wit...   \n",
       "42   Treatment of T-cell acute lymphoblastic leukem...   \n",
       "50   As a component of a multi-agent chemotherapeut...   \n",
       "53   Treatment of adult and pediatric patients with...   \n",
       "56   Treatment of adult and pediatric patients with...   \n",
       "57   Treatment of adult and pediatric patients with...   \n",
       "59   Treatment of pediatric patients 2 years of age...   \n",
       "60   Treatment of blastic plasmacytoid dendritic ce...   \n",
       "62   Remission induction and remission consolidatio...   \n",
       "63   Treatment of patients up to 25 years of age wi...   \n",
       "64   Palliative treatment of malignancies including...   \n",
       "65   Palliative treatment of malignancies including...   \n",
       "66   Palliative treatment of malignancies including...   \n",
       "71   Treatment of adult and pediatric patients 1 ye...   \n",
       "80   Treatment of adult and pediatric patients 12 y...   \n",
       "81   Treatment of CD19-positive Philadelphia chromo...   \n",
       "84   Treatment of adult and pediatric patients 1 ye...   \n",
       "86   Treatment of pediatric patients 1 year of age ...   \n",
       "87   Treatment of pediatric patients 1 year of age ...   \n",
       "90   Pediatric patients with newly diagnosed Philad...   \n",
       "91   Newly diagnosed adult and pediatric patients w...   \n",
       "92   Treatment of relapsed or refractory CD22-posit...   \n",
       "93   Treatment of adult and pediatric patients grea...   \n",
       "94   Treatment of pediatric patients greater than o...   \n",
       "95   Treatment of pediatric patients greater than o...   \n",
       "96   Treatment of pediatric patients aged 6 months ...   \n",
       "97   Treatment of pediatric patients aged 6 months ...   \n",
       "107                                                NaN   \n",
       "108                                                NaN   \n",
       "109                                                NaN   \n",
       "\n",
       "    PEDIATRIC APPROVAL DATE 3* Variation                GENE_ID  \\\n",
       "1                   06-30-2021        --                    NaN   \n",
       "5                   11-18-2011        --                    NaN   \n",
       "14                  11-16-1959        --                    NaN   \n",
       "20                  03-30-2021        --                    NaN   \n",
       "24                  08-07-1974        --                    NaN   \n",
       "32                  11-26-2018        --                    NaN   \n",
       "35                  04-23-2024        --                    NaN   \n",
       "39                  12-07-1953        --                    NaN   \n",
       "40                  12-07-1953        --                    NaN   \n",
       "42                  10-28-2005        --                    NaN   \n",
       "50                  02-01-1994        --                    NaN   \n",
       "53                  06-16-2020        --                    NaN   \n",
       "56                  05-23-2017        --                    NaN   \n",
       "57                  05-23-2017        --                    NaN   \n",
       "59                  04-10-2020        --                    NaN   \n",
       "60                  12-21-2018        --                    NaN   \n",
       "62                          --        --                    NaN   \n",
       "63                  08-30-2017        --                    NaN   \n",
       "64                  11-25-1965        --                    NaN   \n",
       "65                  11-25-1965        --                    NaN   \n",
       "66                  11-25-1965        --                    NaN   \n",
       "71                  09-26-2023  positive    HGNC:1014 | HGNC:76   \n",
       "80                  08-06-2024  Mutation  HGNC:5382 | HGNC:5383   \n",
       "81                  06-14-2024  positive              HGNC:1633   \n",
       "84                  07-14-2022  positive               HGNC:427   \n",
       "86                  12-21-2018  positive    HGNC:1014 | HGNC:76   \n",
       "87                  11-09-2017  positive    HGNC:1014 | HGNC:76   \n",
       "90                  01-25-2013  positive    HGNC:1014 | HGNC:76   \n",
       "91                  09-27-2006  positive    HGNC:1014 | HGNC:76   \n",
       "92                  03-06-2024  positive              HGNC:1643   \n",
       "93                  03-22-2018  positive    HGNC:1014 | HGNC:76   \n",
       "94                  03-22-2018  positive    HGNC:1014 | HGNC:76   \n",
       "95                  03-22-2018  positive    HGNC:1014 | HGNC:76   \n",
       "96                  12-02-2021  positive              HGNC:7315   \n",
       "97                  12-02-2021  positive              HGNC:7315   \n",
       "107                        NaN       NaN                    NaN   \n",
       "108                        NaN       NaN                    NaN   \n",
       "109                        NaN       NaN                    NaN   \n",
       "\n",
       "    GENETIC_LABELS                                     DISEASE_LABELS  \\\n",
       "1               --  hypersensitivity to E. coli-derived asparagina...   \n",
       "5               --  hypersensitivity to E. coli-derived asparagina...   \n",
       "14              --                                                 --   \n",
       "20              --  therapy related acute myeloid leukemia/AML wit...   \n",
       "24              --                                                 --   \n",
       "32              --  solid tumors that have a neurotrophic receptor...   \n",
       "35              --       gastroenteropancreatic neuroendocrine tumors   \n",
       "39              --                               Non-hodgkin Lymphoma   \n",
       "40              --                                      Osteosarcoma    \n",
       "42              --                      T-cell lymphoblastic lymphoma   \n",
       "50              --  hypersensitivity to native forms of L-asparagi...   \n",
       "53              --  mutational burden-high[â‰¥10 mutations/megabase]...   \n",
       "56              --   mismatch repair deficientsolid tumors | Neoplasm   \n",
       "57              --  microsatellite instability-highsolid tumors | ...   \n",
       "59              --                          Neurofibromatosis Type 1    \n",
       "60              --  Blastic Plasmacytoid Dendritic Cell Neoplasm |...   \n",
       "62              --  Acute nonlymphocytic leukemia | acute myeloid ...   \n",
       "63              --      B-cell precursor acute lymphoblastic leukemia   \n",
       "64              --                     testicular germ cell carcinoma   \n",
       "65              --                                   histiocytosis X    \n",
       "66              --                                  Hodgkinâ€™s disease   \n",
       "71      BCR | ABL1  Philadelphia chromosome positive chronic myelo...   \n",
       "80     IDH1 | IDH2                                Grade 2 astrocytoma   \n",
       "81            CD19      B-cell precursor acute lymphoblastic leukemia   \n",
       "84             ALK                Inflammatory Myofibroblastic Tumor    \n",
       "86      BCR | ABL1                      Acute Lymphoblastic Leukemia    \n",
       "87      BCR | ABL1  Philadelphia chromosome positive chronic myelo...   \n",
       "90      BCR | ABL1                      Acute Lymphoblastic Leukemia    \n",
       "91      BCR | ABL1  Philadelphia chromosome positive chronic myelo...   \n",
       "92            CD22      B-cell precursor acute lymphoblastic leukemia   \n",
       "93      BCR | ABL1  Philadelphia chromosome positive chronic myelo...   \n",
       "94      BCR | ABL1  accelerated phase Philadelphia chromosome posi...   \n",
       "95      BCR | ABL1  Philadelphia chromosome positive chronic myelo...   \n",
       "96           MS4A1                              B-cell acute leukemia   \n",
       "97           MS4A1                              Burkitt-like lymphoma   \n",
       "107            NaN                                                NaN   \n",
       "108            NaN                                                NaN   \n",
       "109            NaN                                                NaN   \n",
       "\n",
       "        DISEASE_ID method_ID method_name method_match_type  \n",
       "1    MONDO:0005271      None        None          no match  \n",
       "5    MONDO:0005271      None        None          no match  \n",
       "14             NaN      None        None           skipped  \n",
       "20   MONDO:0019457      None        None          no match  \n",
       "24             NaN      None        None           skipped  \n",
       "32   MONDO:0700215      None        None          no match  \n",
       "35   MONDO:0024503      None        None          no match  \n",
       "39   MONDO:0018908      None        None          no match  \n",
       "40   MONDO:0009807      None        None          no match  \n",
       "42   MONDO:0044917      None        None          no match  \n",
       "50   MONDO:0005271      None        None          no match  \n",
       "53   MONDO:0005070      None        None          no match  \n",
       "56   MONDO:0005070      None        None          no match  \n",
       "57   MONDO:0005070      None        None          no match  \n",
       "59   MONDO:0018975      None        None          no match  \n",
       "60   MONDO:0005070      None        None          no match  \n",
       "62   MONDO:0018874      None        None          no match  \n",
       "63   MONDO:0020511      None        None          no match  \n",
       "64   MONDO:0010108      None        None          no match  \n",
       "65   MONDO:0018310      None        None          no match  \n",
       "66   MONDO:0004952      None        None          no match  \n",
       "71   MONDO:0011996      None        None          no match  \n",
       "80   MONDO:0021638      None        None          no match  \n",
       "81   MONDO:0020511      None        None          no match  \n",
       "84   MONDO:0015798      None        None          no match  \n",
       "86   MONDO:0004967      None        None          no match  \n",
       "87   MONDO:0011996      None        None          no match  \n",
       "90   MONDO:0004967      None        None          no match  \n",
       "91   MONDO:0011996      None        None          no match  \n",
       "92   MONDO:0020511      None        None          no match  \n",
       "93   MONDO:0011996      None        None          no match  \n",
       "94   MONDO:0021367      None        None          no match  \n",
       "95   MONDO:0011996      None        None          no match  \n",
       "96   MONDO:0004947      None        None          no match  \n",
       "97   MONDO:0003658      None        None          no match  \n",
       "107            NaN       NaN         NaN               NaN  \n",
       "108            NaN       NaN         NaN               NaN  \n",
       "109            NaN       NaN         NaN               NaN  "
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "unannotated_method_rows = annotated_with_matches_df[\n",
    "    (annotated_with_matches_df[\"method_ID\"].isna())\n",
    "]\n",
    "unannotated_method_rows"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "DISEASE_LABELS\n",
       "Philadelphia chromosome positive chronic myeloid leukemia                         5\n",
       "B-cell precursor acute lymphoblastic leukemia                                     3\n",
       "--                                                                                2\n",
       "Acute Lymphoblastic Leukemia                                                      2\n",
       "hypersensitivity to E. coli-derived asparaginase| Allergic Disease                1\n",
       "Blastic Plasmacytoid Dendritic Cell Neoplasm | Neoplasm                           1\n",
       "B-cell acute leukemia                                                             1\n",
       "accelerated phase Philadelphia chromosome positive myeloid leukemia               1\n",
       "Inflammatory Myofibroblastic Tumor                                                1\n",
       "Grade 2 astrocytoma                                                               1\n",
       "Hodgkinâ€™s disease                                                                 1\n",
       "histiocytosis X                                                                   1\n",
       "testicular germ cell carcinoma                                                    1\n",
       "Acute nonlymphocytic leukemia | acute myeloid leukemia                            1\n",
       "Neurofibromatosis Type 1                                                          1\n",
       "hypersensitivity to E. coli-derived asparaginase | Allergic Disease               1\n",
       "microsatellite instability-highsolid tumors | Neoplasm                            1\n",
       "mismatch repair deficientsolid tumors | Neoplasm                                  1\n",
       "mutational burden-high[â‰¥10 mutations/megabase] solid tumors | Neoplasm            1\n",
       "hypersensitivity to native forms of L-asparaginase | Allergic Disease             1\n",
       "T-cell lymphoblastic lymphoma                                                     1\n",
       "Osteosarcoma                                                                      1\n",
       " Non-hodgkin Lymphoma                                                             1\n",
       "gastroenteropancreatic neuroendocrine tumors                                      1\n",
       "solid tumors that have a neurotrophic receptor tyrosine kinasegene fusion         1\n",
       "therapy related acute myeloid leukemia/AML with myelodysplasia-related changes    1\n",
       "Burkitt-like lymphoma                                                             1\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "unannotated_method_rows[\"DISEASE_LABELS\"].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
